Dr Randeep Guleria, Director, AIIMS Delhi, has said that in India, there are COVID-19 vaccines which are in their final trial stage.  Speaking to news agency ANI, he said that he is hopeful that by the end of this month or early next month, emergency use authorization from Indian regulatory authorities with be given to a vaccine, which can then be used to vaccinate the general public.

Once booster dose is given, vaccine will give good amount of anti-body production & will start giving protection. This will last for many months giving protection for a significant time when numbers will be less. We need to see type of immunity vaccine gives: Dr Randeep Guleria

In beginning, vaccine won’t be available in sufficient doses to give to everyone. We need a priority list to see that we vaccinate those who’ve high chances of dying due to Covid. Elderly, people with comorbidities & front line workers should be vaccinated 1st: Dr Randeep Guleria